½ÃÀ庸°í¼­
»óǰÄÚµå
1652109

¼¼°èÀÇ ¿ø°Ý¾à±¹ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Çâ, ¾÷°è ºÐ¼® : À¯Çüº°, ÄÄÆ÷³ÍÆ®º°, Á¦°ø ¹æ½Äº°, µð¹ÙÀ̽ºº°, ¿ëµµº°, Áö¿ªº° - ¿¹Ãø(2025-2034³â)

Telepharmacy Market Size, Share, Trends, Industry Analysis Report: By Type, Component, Delivery Mode, Devices, Application, and Region - Market Forecast, 2025-2034

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 118 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é ¼¼°èÀÇ ¿ø°Ý¾à±¹ ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö 689¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù. ÇöÀç ½ÃÀå ¿ªÇÐÀÇ »ó¼¼ ÀλçÀÌÆ®¿Í ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ °üÇÑ ºÐ¼®À» Á¦°øÇϰí ÀÖ½À´Ï´Ù.

¿ø°Ý¾à±¹Àº ¿ø°Ý Åë½Å ±â¼úÀ» ÅëÇØ ÀǾàǰ ¼­ºñ½º¸¦ Á¦°øÇÏ´Â °ÍÀ¸·Î, ¾à»ç°¡ Á÷Á¢ ´ë¸éÇÏÁö ¾Ê°íµµ »ó´ã, Á¶Á¦, ±âŸ ÀǾàǰ °ü¸® ¼­ºñ½º¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¿ø°Ý ¾à±¹ ½ÃÀåÀº ƯÈ÷ ÀÇ·á ¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ª°ú ³óÃÌ Áö¿ª¿¡¼­ ¿ø°ÝÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ´Ù¸¥ ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î´Â ¿ø°ÝÀÇ·áÀÇ È®´ë, Ŭ¶ó¿ìµå ±â¹Ý ¹× AI ±â¼úÀÇ ¹ßÀü, È¿À²ÀûÀÎ ¾à¹° °ü¸®¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ Æ¯È÷ COVID-19 ÆÒµ¥¹Í ÀÌÈÄ ¿ø°Ý ¾à¼öó¸® ¼­ºñ½ºÀÇ ±¤¹üÀ§ÇÑ Ã¤ÅÃÀ» °¡´ÉÇÏ°Ô ÇÏ´Â ±ÔÁ¦ º¯°æµµ ½ÃÀåÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

¿ø°Ý¾à±¹ ½ÃÀå ±âȸ´Â ¿ä¾ç¿ø, ±³µµ¼Ò, ±ººÎ´ë µî ±âÁ¸°ú´Â ´Ù¸¥ ȯ°æÀ¸·ÎÀÇ ¼­ºñ½º È®´ë¿¡ ÀÖ½À´Ï´Ù. ÇöÀç Ãß¼¼´Â ¸ð¹ÙÀÏ Çコ ÅëÇÕÀÇ ºÎ»ó, ¿ø°Ý Á¶Á¦ ÀÚµ¿È­, °³ÀÎÈ­µÈ ȯÀÚ °ü¸®¸¦ À§ÇÑ µðÁöÅÐ Ç÷§ÆûÀÇ Ã¤Åà µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õµéÀÌ È¯ÀÚÀÇ Á¢±Ù¼º, ¾ÈÀü¼º, º¹¾à ¼øÀÀµµ¸¦ Çâ»ó½Ã۱â À§ÇØ µðÁöÅÐ ¼Ö·ç¼ÇÀ» äÅÃÇÏ´Â »ç·Ê°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¿ø°Ý¾à±¹½´Æ¼Äà ½ÃÀåÀº Áö¼ÓÀûÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿ø°Ý¾à±¹ ½ÃÀå : ºÐ¼® °³¿ä

À¯Çüº°·Î´Â ¿ø°Ý Á¶Á¦ ºÐ¾ß°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖÀ¸¸ç, ƯÈ÷ ³ó¾îÃÌ ¹× ¼­ºñ½º ¼Ò¿ÜÁö¿ª¿¡¼­ Á¢±Ù¼º ³ôÀº ÀǾàǰ ¹è¼Û¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ´Â °ÍÀÌ ±× ¹è°æÀÔ´Ï´Ù. ¶ÇÇÑ ¿ø°ÝÀÇ·á µµÀÔ Áõ°¡¿Í È¿À²ÀûÀÎ ÀǾàǰ ¼­ºñ½ºÀÇ Çʿ伺À¸·Î ÀÎÇØ °¡Àå ³ôÀº ¼ºÀåÀ» ±â·ÏÇϰí ÀÖ½À´Ï´Ù.

ÄÄÆ÷³ÍÆ®º°·Î´Â È¿À²ÀûÀÎ Åõ¾à °ü¸®¿Í ¿ø°Ý »ó´ãÀ» °¡´ÉÇÏ°Ô ÇÏ´Â ÅëÇÕÇü ¿ø°Ý¾à±¹ Ç÷§Æû¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ÈûÀÔ¾î ¼ÒÇÁÆ®¿þ¾î ºÐ¾ß°¡ °¡Àå Å« ¿ø°Ý¾à±¹ ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Å¬¶ó¿ìµå ±â¹ÝÀÇ ±â¼ú Çõ½Å°ú AI·Î ÀÎÇØ °¡Àå ³ôÀº ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

Á¦°ø ¹æ½Äº°·Î´Â Ŭ¶ó¿ìµå ±â¹Ý ºÎ¹®ÀÌ ½ÃÀå Á¡À¯À²°ú ¼ºÀå·ü¿¡¼­ ¼±µÎ¸¦ ´Þ¸®°í ÀÖÀ¸¸ç, À¯¿¬¼º, È®À强, ºñ¿ë È¿À²¼ºÀ» Á¦°øÇÏ¸ç ¿ø°Ý ¾à±¹ º¸±Þ¿¡ ÇʼöÀûÀÎ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á ¼­ºñ½º¿¡¼­ Ŭ¶ó¿ìµå ±â¼úÀÌ ÅëÇյǰí ÀÖ´Â °Íµµ ¼ºÀåÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù.

±â±âº°·Î´Â ½º¸¶Æ®Æù/ÅÂºí¸´ ´Ü¸»±â ºÐ¾ß°¡ °¡Àå Å« ºñÁßÀ» Â÷ÁöÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ¿ø°Ý ¾à±¹¿¡¼­ÀÇ ¾à¹° »ó´ã ¹× ó¹æ °ü¸® µî ÀÇ·á ¼­ºñ½º Á¢±Ù¿¡ ÀÖÀ¸¸ç, ¸ð¹ÙÀÏ ±â±â¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö°í Àֱ⠶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ ÀÌ ºÎ¹®Àº ¸ð¹ÙÀÏ Çコ ¾ÛÀÇ º¸±ÞÀ¸·Î °¡Àå ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

¿ëµµº°·Î´Â º´¿øÀÌ ¿ø°Ý¾à±¹ ½ÃÀå¿¡¼­ °¡Àå Å« ºñÁßÀ» Â÷ÁöÇϰí ÀÖÀ¸¸ç, ÷´Ü ÀÇ·á ÀÎÇÁ¶ó¿Í ±¤¹üÀ§ÇÑ º´¿ø ½Ã½ºÅÛ¿¡ ¿ø°Ý¾à±¹ ¼Ö·ç¼ÇÀÇ ÅëÇÕÀ» ÅëÇØ ÇýÅÃÀ» ´©¸®°í ÀÖ½À´Ï´Ù. ¼Ò±Ô¸ð ¾à±¹ ºÎ¹®Àº ¾à±¹µéÀÌ Á¡Á¡ ´õ ¸¹Àº ¾à±¹µéÀÌ ¿ø°Ý¾à±¹ ¼Ö·ç¼ÇÀ» äÅÃÇÏ¿© ¹üÀ§¸¦ È®ÀåÇÔ¿¡ µû¶ó °¡Àå ³ôÀº ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

ºÏ¹Ì´Â źźÇÑ ÀÇ·á ÀÎÇÁ¶ó, ±¤¹üÀ§ÇÑ ¿ø°ÝÀÇ·á µµÀÔ, °­·ÂÇÑ ±ÔÁ¦ Áö¿øÀ» ¹ÙÅÁÀ¸·Î ¼¼°è ½ÃÀåÀ» Àå¾ÇÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÅÚ·¹ÆÄ½Ã ½ÃÀåÀº Àεµ, Áß±¹, ÀϺ»°ú °°Àº ±¹°¡µéÀÇ ÀÇ·á ¼ö¿ä Áõ°¡¿Í ºü¸¥ µðÁöÅÐ ÀÇ·á µµÀÔ¿¡ ÈûÀÔ¾î °¡Àå ³ôÀº ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷¿¡´Â Teladoc Health, Pharmalink, MedPharm, Cerner Corporation, ScriptPro, TelePharm, MediSprout, PipelineRx, Pharmacy Automation Systems, Omnicare, Pharmasimple, Healthway Services, HealthHub, CVS Health, McKesson Corporation µîÀÌ ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå °³¿ä

Á¦3Àå ºÐ¼® ¹æ¹ý

Á¦4Àå ¿ø°Ý¾à±¹ ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ½º³À¼ô
  • ¿ø°Ý¾à±¹ ½ÃÀå ¿ªÇÐ
    • ÃËÁø¿äÀΰú ±âȸ
      • ¿ø°ÝÀÇ·á Á¦°ø ¸ðµåÀÇ Ã¤ÅÃ
      • ÀΰøÁö´É(AI)°ú ±â°èÇнÀ(ML)ÀÇ ÅëÇÕ
    • ¾ïÁ¦¿äÀΰú °úÁ¦
      • ÀÎÅͳݿ¡ ´ëÇÑ ³ôÀº ÀÇÁ¸µµ
  • PESTLE ºÐ¼®
  • ¿ø°Ý¾à±¹ ½ÃÀå µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • COVID-19ÀÇ ¿µÇ⠺м®

Á¦5Àå ¼¼°èÀÇ ¿ø°Ý¾à±¹ ½ÃÀå : À¯Çüº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • ÀÔ¿ø ȯÀÚ
  • ¿ø°Ý Á¶Á¦
  • ¼ö¾×(IV) È¥ÇÕ
  • ¿ø°Ý Ä«¿î¼¿¸µ

Á¦6Àå ¼¼°èÀÇ ¿ø°Ý¾à±¹ ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • Çϵå¿þ¾î
  • ¼ÒÇÁÆ®¿þ¾î

Á¦7Àå ¼¼°èÀÇ ¿ø°Ý¾à±¹ ½ÃÀå : Á¦°ø ¹æ½Äº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • ¿ÂÇÁ·¹¹Ì½º
  • À¥±â¹Ý
  • Ŭ¶ó¿ìµå ±â¹Ý

Á¦8Àå ¼¼°èÀÇ ¿ø°Ý¾à±¹ ½ÃÀå : µð¹ÙÀ̽ºº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • ÄÄÇ»ÅÍ
  • ½º¸¶Æ®Æù
  • ÅÂºí¸´
  • Ű¿À½ºÅ©

Á¦9Àå ¼¼°èÀÇ ¿ø°Ý¾à±¹ ½ÃÀå : ¿ëµµº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • º´¿ø
  • ¼Ò±Ô¸ð ¾à±¹
  • ¿ä¾ç¿ø
  • Çü¹«¼Ò
  • ±º ±âÁö
  • ±ºÇÔ

Á¦10Àå ¼¼°èÀÇ ¿ø°Ý¾à±¹ ½ÃÀå : Áö¿ªº°

  • ÁÖ¿ä ºÐ¼® °á°ú
  • ¼­·Ð
    • ¿ø°Ý¾à±¹ ½ÃÀå Æò°¡ : Áö¿ªº°(2020-2034³â)
  • ºÏ¹Ì
    • ºÏ¹Ì : À¯Çüº°(2020-2034³â)
    • ºÏ¹Ì : ÄÄÆ÷³ÍÆ®º°(2020-2034³â)
    • ºÏ¹Ì : Á¦°ø ¹æ½Äº°(2020-2034³â)
    • ºÏ¹Ì : µð¹ÙÀ̽ºº°(2020-2034³â)
    • ºÏ¹Ì : ¿ëµµº°(2020-2034³â)
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • À¯·´ : À¯Çüº°(2020-2034³â)
    • À¯·´ : ÄÄÆ÷³ÍÆ®º°(2020-2034³â)
    • À¯·´ : Á¦°ø ¹æ½Äº°(2020-2034³â)
    • À¯·´ : µð¹ÙÀ̽ºº°(2020-2034³â)
    • À¯·´ : ¿ëµµº°(2020-2034³â)
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³×´ú¶õµå
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : À¯Çüº°(2020-2034³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ÄÄÆ÷³ÍÆ®º°(2020-2034³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : Á¦°ø ¹æ½Äº°(2020-2034³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : µð¹ÙÀ̽ºº°(2020-2034³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ¿ëµµº°(2020-2034³â)
    • Áß±¹
    • Àεµ
    • ¸»·¹À̽þÆ
    • ÀϺ»
    • Àεµ³×½Ã¾Æ
    • Çѱ¹
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : À¯Çüº°(2020-2034³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÄÄÆ÷³ÍÆ®º°(2020-2034³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Á¦°ø ¹æ½Äº°(2020-2034³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : µð¹ÙÀ̽ºº°(2020-2034³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¿ëµµº°(2020-2034³â)
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : À¯Çüº°(2020-2034³â)
    • ¶óƾ¾Æ¸Þ¸®Ä« : ÄÄÆ÷³ÍÆ®º°(2020-2034³â)
    • ¶óƾ¾Æ¸Þ¸®Ä« : Á¦°ø ¹æ½Äº°(2020-2034³â)
    • ¶óƾ¾Æ¸Þ¸®Ä« : µð¹ÙÀ̽ºº°(2020-2034³â)
    • ¶óƾ¾Æ¸Þ¸®Ä« : ¿ëµµº°(2020-2034³â)
    • ¸ß½ÃÄÚ
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«

Á¦11Àå °æÀï ±¸µµ

  • »ç¾÷ È®´ë¡¤±â¾÷ Àμö ºÐ¼®
    • »ç¾÷ È®´ë
    • ±â¾÷ Àμö
  • Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³

Á¦12Àå ±â¾÷ °³¿ä

  • Teladoc Health
  • Pharmalink
  • MedPharm
  • Cerner Corporation
  • ScriptPro
  • TelePharm
  • MediSprout
  • PipelineRx
  • Pharmacy Automation Systems
  • Omnicare
KSA 25.03.13

The global telepharmacy market size is expected to reach USD 68.98 billion by 2034, according to a new study by Polaris Market Research. The report "Telepharmacy Market Size, Share, Trends, Industry Analysis Report: By Type, Component (Hardware and Software), Delivery Mode, Devices, Application, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Telepharmacy is the provision of pharmaceutical services through remote communication technologies, allowing pharmacists to offer consultations, medication dispensing, and other pharmaceutical care services without the need for in-person interactions.

The telepharmacy market is experiencing significant growth, driven by increasing demand for remote healthcare services, particularly in underserved and rural areas. Other key market drivers include the expansion of telemedicine, advancements in cloud-based and AI technologies, and the growing need for efficient medication management. The market is also supported by regulatory changes that allow for broader adoption of telepharmacy services, particularly after the COVID-19 pandemic.

Telephramacy market opportunities lie in expanding services to non-traditional settings such as nursing homes, prisons, and military bases. Current trends include the rise of mobile health integration, automation in remote dispensing, and the adoption of digital platforms for personalized patient care. Overall, the telepharmacy market is expected to continue growing as healthcare providers increasingly adopt digital solutions to improve patient access, safety, and medication adherence.

Key Highlights of Telepharmacy Market Report

Based on type, the remote dispensing segment dominates the market, driven by the increasing demand for accessible medication delivery, particularly in rural and underserved areas. It is also registering the highest growth due to the rise in telehealth adoption and the need for efficient pharmaceutical services.

Based on component, the software segment holds the largest telepharmacy market share, fueled by the growing demand for integrated telepharmacy platforms that enable efficient medication management and remote consultations. It is also seeing the highest growth, driven by innovations in cloud-based technology and AI.

By delivery mode, the cloud-based segment leads in market share and growth, offering flexibility, scalability, and cost-effectiveness, which are crucial for widespread telepharmacy adoption. Its growth is also accelerated by the increasing integration of cloud technology in healthcare services.

Based on devices, the smartphones and tablets segment holds the largest share, driven by the growing reliance on mobile devices for accessing healthcare services, including telepharmacy consultations and prescription management. This segment is also growing the fastest due to the widespread adoption of mobile health apps.

By application, hospitals represent the largest segment in the telepharmacy market, benefiting from advanced healthcare infrastructure and the integration of telepharmacy solutions into broader hospital systems. The small pharmacies segment is registering the highest growth as pharmacies increasingly adopt telepharmacy solutions to expand their reach.

North America dominates the global market, supported by robust healthcare infrastructure, widespread telehealth adoption, and strong regulatory support. The Asia Pacific telepharmacy market is experiencing the highest growth, driven by increasing healthcare demand and rapid digital healthcare adoption across countries like India, China, and Japan.

Some of the key players in the market include Teladoc Health, Pharmalink, MedPharm, Cerner Corporation, ScriptPro, TelePharm, MediSprout, PipelineRx, Pharmacy Automation Systems, Omnicare, Pharmasimple, Healthway Services, HealthHub, CVS Health, McKesson Corporation.

Polaris Market Research has segmented the telepharmacy market report on the basis of type, component, delivery mode, devices, application, and region:

By Type Outlook (Revenue-USD Billion, 2020-2034)

  • Inpatient
  • Remote Dispensing
  • IV Admixture
  • Remote Counselling

By Component Outlook (Revenue-USD Billion, 2020-2034)

  • Hardware
  • Software

By Delivery Mode Outlook (Revenue-USD Billion, 2020-2034)

  • On-Premises
  • Web-Based
  • Cloud-Based

By Devices Outlook (Revenue-USD Billion, 2020-2034)

  • Computers
  • Smartphones
  • Tablets
  • Kiosk

By Application Outlook (Revenue-USD Billion, 2020-2034)

  • Hospitals
  • Small Pharmacies
  • Nursing Home
  • Prisons
  • Military Base
  • War Ships

By Regional Outlook (Revenue-USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Telepharmacy Market Insights

  • 4.1. Telepharmacy Market - Devices Snapshot
  • 4.2. Telepharmacy Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Adoption of Telehealth Delivery Modes
      • 4.2.1.2. Integration of Artificial Intelligence (AI) and Machine Learning (ML)
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High dependency on internet
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Telepharmacy Market Trends
  • 4.6. Value Chain Analysis

5. Global Telepharmacy Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Inpatient
    • 5.3.1. Global Telepharmacy Market, Inpatient, by Region, 2020-2034 (USD Billion)
  • 5.4. Remote Dispensing
    • 5.4.1. Global Telepharmacy Market, by Remote Dispensing, by Region, 2020-2034 (USD Billion)
  • 5.5. IV Admixture
    • 5.5.1. Global Telepharmacy Market, by IV Admixture, by Region, 2020-2034 (USD Billion)
  • 5.6. Remote Counselling
    • 5.6.1. Global Telepharmacy Market, by Remote Counselling, by Region, 2020-2034 (USD Billion)

6. Global Telepharmacy Market, by Component

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  • 6.3. Hardware
    • 6.3.1. Global Telepharmacy Market, by Hardware, by Region, 2020-2034 (USD Billion)
  • 6.4. Software
    • 6.4.1. Global Telepharmacy Market, by Software, by Region, 2020-2034 (USD Billion)

7. Global Telepharmacy Market, by Delivery Mode

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  • 7.3. On-Premises
    • 7.3.1. Global Telepharmacy Market, by On-Premises, by Region, 2020-2034 (USD Billion)
  • 7.4. Web-Based
    • 7.4.1. Global Telepharmacy Market, Web-Based, by Region, 2020-2034 (USD Billion)
  • 7.5. Cloud-Based
    • 7.5.1. Global Telepharmacy Market, Cloud-Based, by Region, 2020-2034 (USD Billion)

8. Global Telepharmacy Market, by Devices

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  • 8.3. Computers
    • 8.3.1. Global Telepharmacy Market, by Computers, by Region, 2020-2034 (USD Billion)
  • 8.4. Smartphones
    • 8.4.1. Global Telepharmacy Market, by Smartphones, by Region, 2020-2034 (USD Billion)
  • 8.5. Tablets
    • 8.5.1. Global Telepharmacy Market, by Tablets, by Region, 2020-2034 (USD Billion)
  • 8.6. Kiosk
    • 8.6.1. Global Telepharmacy Market, by Kiosk, by Region, 2020-2034 (USD Billion)

9. Global Telepharmacy Market, by Application

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Telepharmacy Market, by Application, 2020-2034 (USD Billion)
  • 9.3. Hospitals
    • 9.3.1. Global Telepharmacy Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 9.4. Small Pharmacies
    • 9.4.1. Global Telepharmacy Market, by Small Pharmacies, by Region, 2020-2034 (USD Billion)
  • 9.5. Nursing Home
    • 9.5.1. Global Telepharmacy Market, by Nursing Home, by Region, 2020-2034 (USD Billion)
  • 9.6. Prisons
    • 9.6.1. Global Telepharmacy Market, by Prisons, by Region, 2020-2034 (USD Billion)
  • 9.7. Military Base
    • 9.7.1. Global Telepharmacy Market, by Military Base, by Region, 2020-2034 (USD Billion)
  • 9.8. Warship
    • 9.8.1. Global Telepharmacy Market, by Warship, by Region, 2020-2034 (USD Billion)

10. Global Telepharmacy Market, by Geography

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Telepharmacy Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 10.3. Telepharmacy Market - North America
    • 10.3.1. North America: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
    • 10.3.2. North America: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
    • 10.3.3. North America: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
    • 10.3.4. North America: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
    • 10.3.5. North America: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.3.7. Telepharmacy Market - U.S.
      • 10.3.7.1. U.S.: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.3.7.2. U.S.: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.3.7.3. U.S.: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.3.7.4. U.S.: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.3.7.5. U.S.: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.3.8. Telepharmacy Market - Canada
      • 10.3.8.1. Canada: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.3.8.2. Canada: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.3.8.3. Canada: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.3.8.4. Canada: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.3.8.5. Canada: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
  • 10.4. Telepharmacy Market - Europe
    • 10.4.1. Europe: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
    • 10.4.2. Europe: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
    • 10.4.3. Europe: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
    • 10.4.4. Europe: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
    • 10.4.5. Europe: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.4.6. Telepharmacy Market - UK
      • 10.4.6.1. UK: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.4.6.2. UK: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.4.6.3. UK: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.4.6.4. UK: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.4.6.5. UK: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.4.7. Telepharmacy Market - France
      • 10.4.7.1. France: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.4.7.2. France: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.4.7.3. France: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.4.7.4. France: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.4.7.5. France: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.4.8. Telepharmacy Market - Germany
      • 10.4.8.1. Germany: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.4.8.2. Germany: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.4.8.3. Germany: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.4.8.4. Germany: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.4.8.5. Germany: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.4.9. Telepharmacy Market - Italy
      • 10.4.9.1. Italy: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.4.9.2. Italy: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.4.9.3. Italy: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.4.9.4. Italy: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.4.9.5. Italy: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.4.10. Telepharmacy Market - Spain
      • 10.4.10.1. Spain: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.4.10.2. Spain: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.4.10.3. Spain: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.4.10.4. Spain: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.4.10.5. Spain: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.4.11. Telepharmacy Market - Netherlands
      • 10.4.11.1. Netherlands: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.4.11.2. Netherlands: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.4.11.3. Netherlands: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.4.11.4. Netherlands: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.4.11.5. Netherlands: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.4.12. Telepharmacy Market - Russia
      • 10.4.12.1. Russia: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.4.12.2. Russia: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.4.12.3. Russia: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.4.12.4. Russia: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.4.12.5. Russia: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.4.13. Telepharmacy Market - Rest of Europe
      • 10.4.13.1. Rest of Europe: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.4.13.2. Rest of Europe: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.4.13.3. Rest of Europe: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.4.13.4. Rest of Europe: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.4.13.5. Rest of Europe: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
  • 10.5. Telepharmacy Market - Asia Pacific
    • 10.5.1. Asia Pacific: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
    • 10.5.2. Asia Pacific: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
    • 10.5.3. Asia Pacific: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
    • 10.5.4. Asia Pacific: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
    • 10.5.5. Asia Pacific: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.5.6. Telepharmacy Market - China
      • 10.5.6.1. China: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.5.6.2. China: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.5.6.3. China: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.5.6.4. China: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.5.6.5. China: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.5.7. Telepharmacy Market - India
      • 10.5.7.1. India: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.5.7.2. India: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.5.7.3. India: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.5.7.4. India: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.5.7.5. India: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.5.8. Telepharmacy Market - Malaysia
      • 10.5.8.1. Malaysia: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.5.8.2. Malaysia: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.5.8.3. Malaysia: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.5.8.4. Malaysia: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.5.8.5. Malaysia: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.5.9. Telepharmacy Market - Japan
      • 10.5.9.1. Japan: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.5.9.2. Japan: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.5.9.3. Japan: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.5.9.4. Japan: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.5.9.5. Japan: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.5.10. Telepharmacy Market - Indonesia
      • 10.5.10.1. Indonesia: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.5.10.2. Indonesia: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.5.10.3. Indonesia: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.5.10.4. Indonesia: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.5.10.5. Indonesia: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.5.11. Telepharmacy Market - South Korea
      • 10.5.11.1. South Korea: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.5.11.2. South Korea: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.5.11.3. South Korea: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.5.11.4. South Korea: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.5.11.5. South Korea: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.5.12. Telepharmacy Market - Australia
      • 10.5.12.1. Australia: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.5.12.2. Australia: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.5.12.3. Australia: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.5.12.4. Australia: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.5.12.5. Australia: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.5.13. Telepharmacy Market - Rest of Asia Pacific
      • 10.5.13.1. Rest of Asia Pacific: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.5.13.2. Rest of Asia Pacific: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.5.13.3. Rest of Asia Pacific: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.5.13.4. Rest of Asia Pacific: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.5.13.5. Rest of Asia Pacific: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
  • 10.6. Telepharmacy Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
    • 10.6.2. Middle East & Africa: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
    • 10.6.3. Middle East & Africa: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
    • 10.6.4. Middle East & Africa: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
    • 10.6.5. Middle East & Africa: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.6.6. Telepharmacy Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.6.6.2. Saudi Arabia: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.6.7. Telepharmacy Market - UAE
      • 10.6.7.1. UAE: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.6.7.2. UAE: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.6.7.3. UAE: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.6.7.4. UAE: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.6.7.5. UAE: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.6.8. Telepharmacy Market - Israel
      • 10.6.8.1. Israel: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.6.8.2. Israel: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.6.8.3. Israel: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.6.8.4. Israel: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.6.8.5. Israel: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.6.9. Telepharmacy Market - South Africa
      • 10.6.9.1. South Africa: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.6.9.2. South Africa: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.6.9.3. South Africa: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.6.9.4. South Africa: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.6.9.5. South Africa: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.6.10. Telepharmacy Market - Rest of Middle East & Africa
      • 10.6.10.1. Rest of Middle East & Africa: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.6.10.2. Rest of Middle East & Africa: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.6.10.3. Rest of Middle East & Africa: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.6.10.4. Rest of Middle East & Africa: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.6.10.5. Rest of Middle East & Africa: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
  • 10.7. Telepharmacy Market - Latin America
    • 10.7.1. Latin America: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
    • 10.7.2. Latin America: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
    • 10.7.3. Latin America: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
    • 10.7.4. Latin America: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
    • 10.7.5. Latin America: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.7.6. Telepharmacy Market - Mexico
      • 10.7.6.1. Mexico: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.7.6.2. Mexico: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.7.6.3. Mexico: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.7.6.4. Mexico: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.7.6.5. Mexico: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.7.7. Telepharmacy Market - Brazil
      • 10.7.7.1. Brazil: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.7.7.2. Brazil: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.7.7.3. Brazil: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.7.7.4. Brazil: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.7.7.5. Brazil: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.7.8. Telepharmacy Market - Argentina
      • 10.7.8.1. Argentina: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.7.8.2. Argentina: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.7.8.3. Argentina: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.7.8.4. Argentina: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.7.8.5. Argentina: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
    • 10.7.9. Telepharmacy Market - Rest of Latin America
      • 10.7.9.1. Rest of Latin America: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
      • 10.7.9.2. Rest of Latin America: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
      • 10.7.9.3. Rest of Latin America: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
      • 10.7.9.4. Rest of Latin America: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
      • 10.7.9.5. Rest of Latin America: Telepharmacy Market, by Application, 2020-2034 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Teladoc Health
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Pharmalink
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. MedPharm
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Cerner Corporation
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. ScriptPro
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. TelePharm
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. MediSprout
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. PipelineRx
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Pharmacy Automation Systems
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Omnicare
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦